A new study reveals how a common genetic mutation linked to Alzheimer’s disease may accelerate brain cell damage by disrupting the normal breakdown of toxic proteins. Researchers found that the mutation interferes with the brain’s ability to clear amyloid-beta, a key protein associated with the disease, suggesting potential new targets for early intervention. The findings challenge previous assumptions about how the mutation contributes to neurodegeneration, offering fresh insights into possible therapeutic approaches. Experts caution that while promising, the work requires further validation before clinical applications can be explored.
